483
RAPHA Health Network International, Inc.RAPHA Health Network International, Inc. – FDA 483, Dec 16, 2022
Record Details
An FDA inspection of BAPHA Health Network International, Inc., an OTC drug repackager/relabeler in Doral, FL, revealed significant deficiencies in quality control, supplier qualification, deviation management, and batch record documentation. The firm failed to adequately test incoming components, qualify suppliers, investigate deviations, and maintain complete batch production records. These issues indicate a lack of robust quality systems for drug product manufacturing and control.
View Company Profile
ID · 07c7d645-78f9-44c8-b4b9-1bcb7ae23f08
Other documents for RAPHA Health Network International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.